Link to this page
Ontology of Cardiovascular Drug Adverse Events
Last uploaded:
December 29, 2016
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007318
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007318
|
|---|---|
| Preferred Name | Doxazosin [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Doxazosin [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Doxazosin [Chemical/Ingredient]
|
| NUI |
N0000007318
|
| Synonym |
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-
|
| code |
C24988
|
| prefixIRI |
NDF-RT:N0000007318
|
| RxNorm_CUI |
49276
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0026251
|
| MeSH_DUI |
D017292
|
| type | |
| MeSH_Name |
Doxazosin
|
| UMLS_CUI |
C0114873
|
| RxNorm_Name |
Doxazosin
|
| Display_Name |
Doxazosin
|
| MeSH_Definition |
A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |